Parturient Satisfaction With Epidural Analgesia by PCEA or Manual Boluses
NCT ID: NCT06094946
Last Updated: 2024-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-12-31
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor
NCT04645823
Ropivacaine and Fentanyl for Labor Epidural Initiation
NCT07076368
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2
NCT02758405
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor
NCT02550262
A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.
NCT02084589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midwife administered boluses
The epidural analgesia is initiated by a manual bolus of the epidural solution (ropivacaine 1 mg/ml fentanyl 2.5 mug/ml) 10 + 10 ml and then continued on-demand by similar boluses until delivery
Ropivacaine Hydrocloride
1 mg/ml
Fentanyl Citrate
2.5 micrograms/ml
Automated and parturient controlled epidural boluses
The epidural analgesia is initiated by a manual bolus of the epidural solution (ropivacaine 1 mg/ml fentanyl 2.5 mug/ml) 10 + 10 ml and then continued by automated boluses of the same solution (6ml every 40 minutes) with possibility for the parturient to administer 6 ml extra doses with a 20 minute lock-out. Maximum hourly dose 20 ml.
Ropivacaine Hydrocloride
1 mg/ml
Fentanyl Citrate
2.5 micrograms/ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine Hydrocloride
1 mg/ml
Fentanyl Citrate
2.5 micrograms/ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the delivery hospital with the prospect of vaginal delivery
* On admission when questioned about planned analgesia expresses that may want an epidural analgesia for the planned vaginal delivery
* After reading the study prochure signs the participation (consent) form
* Sufficient command of Finnish or Swedish to facilitate interview
Exclusion Criteria
* Planned cesarean delivery
* Age under 18 years
18 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Women's Hospital HUS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antti Vaananen
Anesthesiologist MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Riina Jernman, MD PhD
Role: STUDY_DIRECTOR
Helsinki University Hospital Women's hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HUS/Women's hospital dept of anaesthesia
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCEA_15102023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.